Perspective
Published on 17 Jun 2021
Patient Expectations of Assigned Treatments Impact Strength of Randomised Control Trials
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.648403
- 3,121 views
- 4 citations
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
504 articles
articles
Original Research
Published on 31 May 2021
Evaluation of Consistency of Treatment Response Across Regions—the LEADER Trial in Relation to the ICH E17 Guideline
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.662775
- 4,288 views
- 7 citations
Original Research
Published on 31 May 2021
Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.669509
- 50,922 views
- 48 citations
Brief Research Report
Published on 28 May 2021
Evaluation of Eight-Item Vancomycin Prescribing Confidence Questionnaire Among Junior Doctors
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.677818
- 2,460 views
Original Research
Published on 28 May 2021
A Mixed Methods Process Evaluation of a Clustered-Randomized Controlled Trial to Determine the Effects of Community-Based Dietary Sodium Reduction in Rural China
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.646576
- 5,958 views
- 6 citations
Methods
Published on 21 May 2021
iOntoBioethics: A Framework for the Agile Development of Bioethics Ontologies in Pandemics, Applied to COVID-19
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.619978
- 6,316 views
- 9 citations
Policy and Practice Reviews
Published on 21 May 2021
Digital Innovation in Medicinal Product Regulatory Submission, Review, and Approvals to Create a Dynamic Regulatory Ecosystem—Are We Ready for a Revolution?
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.660808
- 16,020 views
- 31 citations
Original Research
Published on 07 May 2021
Nurses' Ethics in the Care of Patients During the COVID-19 Pandemic
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.589550
- 31,474 views
- 28 citations
Original Research
Published on 12 Apr 2021
Standard Survey Data: Insights Into Private Sector Utilization
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.624285
- 5,674 views
- 23 citations
Original Research
Published on 31 Mar 2021
Deficiencies in Planning Interventional Trial Registration of COVID-19 in China
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.618185
- 3,420 views
Original Research
Published on 30 Mar 2021
Ethical Challenges Related to the Novel Coronavirus (COVID-19) Outbreak: Interviews With Professionals From Saudi Arabia
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.620444
- 30,958 views
- 8 citations
Original Research
Published on 22 Mar 2021
Whom Should Be Saved? A Proposed Ethical Framework for Allocating Scarce Medical Resources to COVID-19 Patients Using Fuzzy Logic
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.600415
- 7,577 views
- 3 citations
Original Research
Published on 11 Mar 2021
Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.643028
- 10,135 views
- 17 citations
Study Protocol
Published on 09 Mar 2021
Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.595797
- 7,715 views
- 10 citations
Policy and Practice Reviews
Published on 09 Mar 2021
A Comparative Study for License Application Regulations on Proprietary Chinese Medicines in Hong Kong and Canada
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.617625
- 6,642 views
- 2 citations
Original Research
Published on 25 Feb 2021
Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.652358
- 12,050 views
- 64 citations
Original Research
Published on 23 Feb 2021
Factors Influencing Participation in COVID-19 Clinical Trials: A Multi-National Study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.608959
- 8,410 views
- 31 citations
Perspective
Published on 12 Feb 2021
Shortages Without Frontiers: Antimicrobial Drug and Vaccine Shortages Impact Far Beyond the Individual!
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.593712
- 5,891 views
- 14 citations
Policy and Practice Reviews
Published on 03 Feb 2021
Medicine Shortages: From Assumption to Evidence to Action - A Proposal for Using the FMD Data Repositories for Shortages Monitoring
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.579822
- 7,455 views
- 7 citations
Original Research
Published on 02 Feb 2021
Paediatric Medicines in Europe: The Paediatric Regulation—Is It Time for Reform?
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.593281
- 14,660 views
- 43 citations
Mini Review
Published on 14 Jan 2021
Allocation of the “Already” Limited Medical Resources Amid the COVID-19 Pandemic, an Iterative Ethical Encounter Including Suggested Solutions From a Real Life Encounter
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2020.616277
- 14,468 views
- 33 citations
Original Research
Published on 12 Jan 2021
The Fair Allocation of Scarce Medical Resources: A Comparative Study From Jordan
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2020.603406
- 25,340 views
- 16 citations
Original Research
Published on 05 Jan 2021
Mixed Method Study to Explore Ethical Dilemmas and Health Care Workers' Willingness to Work Amid COVID-19 Pandemic in Palestine
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2020.576820
- 10,009 views
- 58 citations
Perspective
Published on 23 Dec 2020
Development and Use of Gene Therapy Orphan Drugs—Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and Society
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2020.608249
- 13,582 views
- 21 citations